These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9494609)

  • 21. The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias.
    Mellentin JD; Murre C; Donlon TA; McCaw PS; Smith SD; Carroll AJ; McDonald ME; Baltimore D; Cleary ML
    Science; 1989 Oct; 246(4928):379-82. PubMed ID: 2799390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia].
    Chai YH; Lü H; Li JQ; Lu J; Xiao PF; He YX; Shao XJ
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):684-6. PubMed ID: 18021563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood acute lymphoblastic leukemia with equivocal chromosome markers of the t(1;19) translocation.
    Filatov LV; Behm FG; Pui CH; Head DR; Downing JR; Raimondi SC
    Genes Chromosomes Cancer; 1995 Jun; 13(2):99-103. PubMed ID: 7542913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
    Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
    J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis.
    Hunger SP
    Blood; 1996 Feb; 87(4):1211-24. PubMed ID: 8608207
    [No Abstract]   [Full Text] [Related]  

  • 26. Characterization of the t(17;19) translocation by gene-specific fluorescent in situ hybridization-based cytogenetics and detection of the E2A-HLF fusion transcript and protein in patients' cells.
    Yeung J; Kempski H; Neat M; Bailey S; Smith O; Brady HJ
    Haematologica; 2006 Mar; 91(3):422-4. PubMed ID: 16531271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E2A-PBX1 chimeric transcript status at end of consolidation is not predictive of treatment outcome in childhood acute lymphoblastic leukemias with a t(1;19)(q23;p13): a Pediatric Oncology Group study.
    Hunger SP; Fall MZ; Camitta BM; Carroll AJ; Link MP; Lauer SJ; Mahoney DH; Pullen DJ; Shuster JJ; Steuber CP; Cleary ML
    Blood; 1998 Feb; 91(3):1021-8. PubMed ID: 9446665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study.
    Borowitz MJ; Hunger SP; Carroll AJ; Shuster JJ; Pullen DJ; Steuber CP; Cleary ML
    Blood; 1993 Aug; 82(4):1086-91. PubMed ID: 8353275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials.
    Kamps MP; Look AT; Baltimore D
    Genes Dev; 1991 Mar; 5(3):358-68. PubMed ID: 1672117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The gene encoding the granulocyte colony-stimulating factor receptor is a target for deregulation in pre-B ALL by the t(1;19)-specific oncoprotein E2A-Pbx1.
    de Lau WB; Hurenkamp J; Berendes P; Touw IP; Clevers HC; van Dijk MA
    Oncogene; 1998 Jul; 17(4):503-10. PubMed ID: 9696044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
    Deucher AM; Qi Z; Yu J; George TI; Etzell JE
    Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular variants of the 1;19 chromosomal translocation in pediatric acute lymphoblastic leukemia (ALL).
    Privitera E; Luciano A; Ronchetti D; Aricò M; Santostasi T; Basso G; Biondi A
    Leukemia; 1994 Apr; 8(4):554-9. PubMed ID: 8152250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of the t(1;19)(q23;p13) translocation observed in adult leukemias.
    Mitani K; Sasaki K; Ogawa S; Hayashi Y; Mano H; Yazaki Y; Hirai H
    Int J Hematol; 1994 Dec; 60(4):267-71. PubMed ID: 7894030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype.
    Dahéron L; Brizard F; Millot F; Cividin M; Lacotte L; Guilhot F; Brizard A
    Hematol J; 2002; 3(3):153-6. PubMed ID: 12111652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular investigation of 19p13 in standard and variant translocations: the E12 probe recognizes the 19p13 breakpoint in cases with t(1;19) and acute leukemia other than pre-B immunophenotype.
    Yamada T; Craig JM; Hawkins JM; Janossy G; Secker-Walker LM
    Leukemia; 1991 Jan; 5(1):36-40. PubMed ID: 1999956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia.
    Prima V; Gore L; Caires A; Boomer T; Yoshinari M; Imaizumi M; Varella-Garcia M; Hunger SP
    Leukemia; 2005 May; 19(5):806-13. PubMed ID: 15744350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cytogenetic characterization of TCF3 (E2A)/19p13.3 rearrangements in B-cell precursor acute lymphoblastic leukemia.
    Barber KE; Harrison CJ; Broadfield ZJ; Stewart AR; Wright SL; Martineau M; Strefford JC; Moorman AV
    Genes Chromosomes Cancer; 2007 May; 46(5):478-86. PubMed ID: 17311319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific in vitro amplified probe detects the E2A gene rearrangement in the t(1;19) acute lymphoblastic leukemia.
    Jonveaux P; Bernard O; Hillion J; Berger R
    Leukemia; 1990 Dec; 4(12):808-10. PubMed ID: 2243503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome.
    Lanza C; Gottardi E; Gaidano G; Vivenza C; Parziale A; Perfetto F; Fornaci M; Barisone E; Madon E; Basso G; Saglio G
    Leuk Res; 1996 May; 20(5):441-3. PubMed ID: 8683984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
    Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
    Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.